Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair
This study will evaluate whether adding a suprazygomatic maxillary nerve block to the standard palatal nerve block improves pain control after cleft palate repair surgery in children. Participants will be randomly assigned to receive either the standard palatal block alone or the standard palatal block combined with a suprazygomatic maxillary nerve block. Both techniques use medications commonly used for pain management during surgery.
The purpose of this study is to determine whether the addition of the suprazygomatic maxillary nerve block reduces postoperative pain, decreases the need for opioid medications, and improves recovery after cleft palate repair. Researchers will compare pain scores, medication use, recovery outcomes, and any treatment-related complications between the two groups.
Information collected from this study may help identify the most effective regional anesthesia approach for children undergoing cleft palate repair and may improve postoperative pain management and patient recovery.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Logan Stratton
- Telefonnummer: 443-922-6012
- E-mail: lstratton@childrensnational.org
Undersøgelse Kontakt Backup
- Navn: Albert Oh
- Telefonnummer: 202-713-8856
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Children undergoing primary cleft palate repair or secondary velopharyngeal insufficiency (VPI) surgery.
- Eligible to receive regional anesthetic nerve blocks as part of the planned surgical procedure.
- Parent or legal guardian able and willing to provide informed consent.
- Participant meets all institutional and surgical criteria for undergoing the planned procedure.
Exclusion Criteria:
- Known allergy, hypersensitivity, or contraindication to the study anesthetic medications.
- Medical conditions that contraindicate regional anesthetic nerve block procedures.
- Coagulopathy or bleeding disorder that would increase the risk of nerve block placement.
- Active infection at or near the planned injection site.
- Inability of parent or legal guardian to provide informed consent.
- Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with study assessments.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Standard Palatal Nerve Block
Participants receive the standard palatal nerve block performed during cleft palate surgery. |
Regional anesthetic block of the palate performed during cleft palate or velopharyngeal insufficiency surgery using local anesthetic. This procedure serves as the standard pain management approach and is intended to provide perioperative analgesia and reduce postoperative pain. |
|
Eksperimentel: Standard Palatal Nerve Block Plus Suprazygomatic Maxillary Nerve Block
Participants receive the standard palatal nerve block plus a suprazygomatic maxillary nerve block during cleft palate surgery. |
Regional anesthetic block of the maxillary nerve performed via a suprazygomatic approach using local anesthetic in addition to the standard palatal nerve block. The procedure is intended to enhance perioperative analgesia, decrease postoperative pain, and reduce postoperative opioid requirements following cleft palate or velopharyngeal insufficiency surgery. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Pain Scores Measured by the Face, Legs, Activity, Cry, Consolability (FLACC) Scale
Tidsramme: Within the first 24 hours following surgery
|
Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale following cleft palate repair or velopharyngeal insufficiency surgery. The FLACC scale rates five behavioral categories (Face, Legs, Activity, Cry, and Consolability) from 0 to 2 each, for a total score ranging from a minimum of 0 to a maximum of 10. Higher scores indicate more pain and therefore a worse outcome. Pain scores will be compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block to evaluate the effectiveness of the additional regional anesthesia technique. |
Within the first 24 hours following surgery
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Opioid Consumption
Tidsramme: Within the first 24 hours following surgery
|
Total postoperative opioid medication use will be recorded and compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block. This outcome will assess whether the additional regional anesthesia technique reduces the need for opioid analgesics following surgery. |
Within the first 24 hours following surgery
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Mundsygdomme
- Stomatognatiske sygdomme
- Sygdomme i nervesystemet
- Postoperative komplikationer
- Patologiske processer
- Neuroadfærdsmæssige manifestationer
- Stomatognatiske systemabnormiteter
- Medfødte abnormiteter
- Læbesygdomme
- Perceptuelle forstyrrelser
- Abnormiteter i munden
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Agnosia
- Læbespalte
- Kirurgisk sår dehiscens
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- STUDY00001302
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be shared with researchers outside of the study team. Data collected for this study contain protected health information and were obtained under informed consent and institutional review board requirements that do not include plans for external sharing of individual participant-level data.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .